Efficacy and Safety of Ixekizumab with or Without Methotrexate in Biologic-Naïve Patients with Psoriatic Arthritis: 52-Week Results from SPIRIT-H2H Study

  • Josef S. Smolen (Creator)
  • Anthony I. Sebba (Creator)
  • Eric M Ruderman (Creator)
  • Hendrik Schulze-Koops (Creator)
  • Christophe Sapin (Creator)
  • Amanda M. Gellett (Creator)
  • Aubrey Trevelin Sprabery (Creator)
  • L. Li (Contributor)
  • Inmaculada de la Torre (Contributor)
  • G. Gallo (Creator)
  • Soyi Liu-Leage (Contributor)
  • Sreekumar Pillai (Contributor)
  • Paulo Reis (Creator)
  • Peter Nash (Creator)
  • Peter Nash (Creator)



Article full text The above Summary Slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The authors, CC-BY-NC 2020.
Date made available2020
PublisherAdis Journals

Cite this